|
|
Scientific Research/ Articles |
Influence of pediatric vaccines on amygdala growth and opioid ligand
binding in rhesus macaque infants: A pilot study
Laura Hewitson, Brian J. Lopresti, Carol Stott, N. Scott Mason and Jaime Tomko
Sorting out the spinning of autism: heavy metals and the question of incidence
Mary Catherine DeSoto and Robert T. Hitlan
Seizure Issues In Autism Spectrum Disorders
Jeff Bradstreet MD, MD(H) FAAFP and Dan Rossignol, MD FAAFP
Conference Presentation - Puerto Rico 2008
By James Jeffrey Bradstreet, MD, MD(H) FAAFP, Director ICDRC
Is Autism A G-Alpha Protein Defect Reversible With Natural
Vitamin A?
Mary N. Megson, M.D., F.A.A.P. Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
By Daniel A. Rossignol, Lanier W. Rossignol, Scott Smith, Cindy Schneider, Sally Logerquist, Anju Usman, Jim Neubrander, Eric M. Madren, Gregg Hintz, Barry Grushkin and Elizabeth A. Mumper
Link Between the Vagus Nerve, Cholinergic Deficit, Inflammation, Cognitive Deficits and Inattention: the Soul of the Gut - Brain Connection
By James Jeffrey Bradstreet, MD, MD(H) FAAFP, Director ICDRC and Adjunct Professor, Pediatrics Southwest College of Naturopathic Medicine
Galantamine may be effective in treating autistic disorder
By Helmut Niederhofer, child and adolescent psychiatrist
Galatamine: Effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning
By Diana S. Woodruff-Pak, Richard W. Vogel III and Gary L. Wenk
Galantamine in the Treatment of Adult Autism: A Report of Three Clinical Cases
The Internal Journal of Psychiatry in Medicine
The Alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation
By WJ de Jonge and L Ulloa
Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder
By Alexandra S. Potter, Paul A. Newhouse
Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis
By Sandborn, Tremaine, Offord, Lawson, Petersen, Batts, Croghan, Dale, Schroeder, and Hurt
Evidence of Mitochondrial Dysfunction in Autism and Implications for Treatment
By Daniel A. Rossignol, MD and J. Jeffrey Bradstreet, MD, FAAFP
International Child Development Research Center
Autism: The Clinical Picture
By Jeffrey Bradstreet, MD, FAAFP, International Child Development
Research Center
Stem Cell Therapy for Autism
By Thomas E. Ichim, Fabio Solano, Eduardo Glenn, Frank Morales, Leonard Smith, George Zabrecky and Neil H. Riordan
Stem Cells Show Power To Predict Disease, Drug Toxicity, Maybe Autism
By Czar, Gage, Quam, Smith, Rosa and Brown or UW-Madison;
Piekarczyk of the WiCell Research Institute and Muotri of the Salk Institute
MIT Correct Inherited Retardation, Autism in Mice Research points to
potential drug treatment
Early Thimerosal Exposure and Neuropsychological Outcomes a 7 and 10 Years
The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study
By Daniel A. Rossignol, Lanier W. Rossignol, S. Jill James, Stepan Melnyk and Elizabeth Mumper
Blood Levels of Mercury Are Related to Diagnosis of Autism: A Reanalysis
of an Important Data Set
By M. Catherine DeSotoPhD and Robert T. Hitlan PhD
Evidence Mounts Implicating Lyme Disease in the Autism Epidemic
Study Abstract: The Association Between Tick-Borne Infections, Lyme Borreliosis and Autism Spectrum Disorders
By Robert C. Bransfield, Jeffrey S. Wulfman, William T. Harvey, Anju I. Usman
Urine Testing Confirms Autism is Mercuring Poisoning
by David A. Geier and Dr. Mark R. Geier
Summary of Biomedical Treatments for Autism
By James B. Adams, Ph.D.
Structure of Protein Altered in Autism Revealed
Asperger's Syndrome
Asperger's Syndrome: Do I have it? And how do I live with it?
By Susan J. Golubock and Tara J. Marshall
(Members of the Phoenix Adult Asperger's Support Group)
Environmental Factors in Autism and Steps for Therapy and Recovery
By Jeff Bradstreet, MD, FAAFP, ICDRC and Florida Hospital Celebration, Director
The Best of DAN! Advanced Biomarker Directed interventions
By J. Bradstreet M.D., FAAFP, Dan Rossingnol, M.D. and Scott Smith, PA-C
Simplifiled Evaluation and Treatment of Autism Using Biomarker Directed Algorithms
By Jeff Bradstreet M.D., FAAFP, Dan Rossignol., M.D. and Scott Smith , PA-C
Spironolactone Might be a Desirable Immunlogic and Hormonal Intervention in Autism Spectrum Disorders
By James Jeffrey Bradstreet MD, Scott Smith PA, Doreen Granpeesheh PhD, BCBA, Jane M. El-Dahr MD, Daniel Rossignol MD
Thimerosal Linked to Autism: New Clinical Findings
By David A. Geier, B.A. and Mark R. Geier, M.D., PhD
Thimerosal Exposure During Pregnancy Linked to Autistic Disorder
Thimerosal Safety
By James Jeffrey Bradstreet, M.D., F.A.A.F.P., Director, The International Child Development Resource Center
Hyperbaric Oxygen Therapy Improves Symptoms In Autistic Children
By Dan Rossignol, Elizabeth Mumper, Jill James, Lanier Rossignol
Interview with Dr. Dan A. Rossignol: Hyperbaric oxygen therapy may improve symptoms in autistic children in Medical Hypotheses
Treatment Options for Mercury/Metal Toxicity in Autism and Related Developmental Disabilities: Consensus Position Paper February 2005
Autism Research Institute
Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children
By Andrew J. Wakefield, S.H. Murch. A. Anthony, J. Linnell, D.M. Casson, M. Malik, M. Berelowitz. A. P. Dhillon, M.A. Thomson, P. Harvey, A. Valentine, S.E. Davies, J.A. Walker-Smith
Biological Evidence of Significant Vaccine Related Side-effects Resulting in
Neurodevelopmental Disorders
(Presentation to the Vaccine Safety Committee of the Institute of Medicine, The National Academies of Science, February 9, 2004)
By Jeff Bradstreet, MD
Link between autism and abnormal blood-vessel function and oxidative stress
By Yuemang Yao, William J. Walsh and Woody R. McGinnis, MD
Summary of the American College for Advancement in Medicine November 2005 Conference on Scientific Integrative Medicine: Advancing Health Horizons
By Stephen A. Feig, James Biddle, Eleanor Hynote, Neal Speight, Kenneth Bock, Allan Magaziner and Joseph E. Rich
Mounting Evidence Fingers Mitochondria In Autism Risk
Intensive Behavioral Treatment at School for 4 to 7 Year Old Children With Autism A 1 Year Comparison Controlled Study
By Svein Eikeseth, Tristram Smith, Erik Jahr and Sigmund Eldevik
Porphyrinuria in childhood autistic disorder: Implications for environmental toxicity
By Robert Nataf, Corinne Skorupka, Lorene Amet, Alain Lam, Anthea Springbett and Richard Lathe
A Case Series of Children with Apparent Mercury Toxic Encephalopathies Manifesting with Clinical Symptoms of Regressive Autistic Disorders
By David A. Geier and Mark R. Geier
Mercury Induces an Unopposed Inflammatory Response in Human Peripheral Blood Mononuclear Cells in Vitro
By Renee M. Gardner, Jennifer F. Nyland, Sean L. Evans, Susie B. Wang, Kathleen M. Doyle, Ciprian M. Crainiceanu, and Ellen K. Silbergeld
Methyl-B12: A Treatment for ASD with Methylation Issues
Methyl-B12: Myth, Masterpiece, or Miracle?
By Dr. Neubrander
Research May Unlock Mystery of Autism's Origin in the Brain
Study shows connections between brain cells may be deficient within single regions and not just between regions
Tony Wilson, PhD, Wake Forest University School of Medicine, Donald Rojas, PhD, Martin Reite, M.D., Peter Teale, M.S.E.E., University of Colorado, Sally Rogers, PhD, University of California-Davis
|
|
|